Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 28, 2014 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Hold Second Quarter 2014 Financial Results Webcast and Conference Call

NOVATO, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release second quarter 2014 financial results after market close on Thursday,...
July 07, 2014 16:01 ET | Source: Raptor Pharmaceutical Inc

Raptor Announces CEO Succession Plan; Dr. Christopher Starr to Retire as CEO at Year-end 2014, Julie Anne Smith Named President and CEO-Designate

NOVATO, Calif., July 7, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceuticals (Nasdaq:RPTP) today announced that Julie Anne Smith, Executive Vice President, Strategy and Chief Operating Officer at Raptor,...
July 01, 2014 17:13 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Enters Into $70 Million Financing Transaction and Amended Loan Agreement With HealthCare Royalty Partners

NOVATO, Calif., July 1, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has entered into agreements for $70 million in funding from HealthCare Royalty...
June 24, 2014 07:00 ET | Source: Raptor Pharmaceutical Inc

Data Published in Journal of Pediatrics Demonstrated That PROCYSBI(R) Improved Quality of Life and Preserved Kidney Function in Cystinosis Patients

NOVATO, Calif., June 24, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that data from its open label extension study of delayed-release cysteamine bitartrate...
June 10, 2014 08:00 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Participate in Three Upcoming Investor Conferences in June

NOVATO, Calif., June 10, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will participate in three upcoming investor conferences in...
May 08, 2014 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Reports First Quarter 2014 Financial Results and Provides Corporate Update

Reports PROCYSBI® net product sales of $12.1 million in first quarter 2014 and launch of PROCYSBI® in Germany Company to host conference call and webcast today at 4:30 p.m. EDT...
May 01, 2014 07:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Present at Upcoming Investor Conference

NOVATO, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Bank of America Merrill Lynch 2014 Health Care...
April 30, 2014 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Hold First Quarter 2014 Financial Results Webcast and Conference Call

NOVATO, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release first quarter 2014 financial results after market close on Thursday,...
March 13, 2014 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Corporate Update

2014 guidance of $55-$65 million of net sales for PROCYSBI® Company to host conference call and webcast today at 4:30 p.m. EDT NOVATO, Calif., March 13, 2014 (GLOBE NEWSWIRE) -- Raptor...
March 10, 2014 07:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Hold Fourth Quarter and Full Year 2013 Financial Results Webcast and Conference Call

NOVATO, Calif., March 10, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release fourth quarter and full year 2013 financial results after market close...